You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Radiomics models to predict axillary lymph node metastasis in breast cancer and analysis of the biological significance of radiomic features
- 2. Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy
- 3. Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis
- 4. Millions Stand to Lose Health Coverage Under Proposed Medicaid Cuts, Study Says
- 5. Scientists find new way to predict how bowel cancer drugs will stop working—paving way for smarter treatments
- 6. Breast cancer patients' microbiome may hold key to avoiding damaging heart side-effects of cancer therapies
- 7. Cancer immunotherapy nursing care from 2004 to 2023: a bibliometric analysis
- 8. Thousands of blood cancer patients could benefit from new drug combination
- 9. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 10. Foresee Pharmaceuticals announces reaching a significant milestone, of complete enrollment of its Phase 3 Casppian trial for patients with Central Precocious Puberty (CPP)
Last updated at 10:32 GMT
Hot News Makers
Health/Pharma Companies
-
25033.61
-
7064.41
-
5890.08
-
3521.91
-
3173.62
-
2292.43
-
1803.19
-
1700.09
-
1442.56
-
1184.19
Drugs, Treatments, Trials
-
10340.12
-
3895.14
-
938.45
-
680.06
-
513.79
-
385.34
-
360.94
-
256.89
-
253.10
-
133.81
Last updated at 10:10 GMT
